Indo US Bio-Tech Ltd.
NSE: INDOUS | BSE: 541304
₹72.50
₹0.33
(0.46%)
As on 14-Oct-2026 10:41IST
Market cap
₹144 Cr
Revenue (TTM)
₹113 Cr
P/E Ratio
12.6
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹11 Cr
-
ROE
15.3 %
-
ROCE
14.5 %
-
Industry P/E
14.42
-
EV/EBITDA
11.2
-
Debt to Equity
0.4
-
Book Value
₹47.7
-
EPS
₹5.7
-
Face value
10
-
Shares outstanding
20,052,000
10 Years Aggregate
CFO
₹-17.18 Cr
EBITDA
₹79.58 Cr
Net Profit
₹61.31 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indo Us Bio-Tech
| -40.4 | -7.3 | -19.2 | -45.4 | -- | -- | -- |
|
BSE FMCG
| -14.9 | -0.1 | -6.0 | -14.5 | -3.4 | 2.5 | 7.3 |
|
Company
|
2025
|
|---|---|
|
Indo Us Bio-Tech
| -59.4 |
|
BSE Small Cap
| -6.6 |
|
BSE FMCG
| -2.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indo Us Bio-Tech
|
72.5 | 144.4 | 112.7 | 11.5 | 12.9 | 12.8 | 12.6 | 1.5 |
| 220.1 | 2,266.7 | 2,287.1 | 103.3 | -- | 15.9 | 21.9 | 1.6 | |
| 287.7 | 1,416.9 | 1,478.2 | 125.1 | 11.2 | 15.7 | 11.3 | 1.8 | |
| 91.9 | 1,890.2 | 1,868.9 | 78.4 | 5.3 | 14.2 | 24.7 | 3.0 | |
| 236.0 | 304.7 | 730.1 | 32.5 | 4.0 | 19.5 | 9.6 | 1.7 | |
| 716.9 | 3,658.1 | 1,278.7 | 248.5 | 18.2 | 14.1 | 14.7 | 1.8 | |
| 3.1 | 329.8 | 771.8 | 177.5 | 23.4 | 14.4 | 1.9 | 0.3 | |
| 138.9 | 258.5 | 489.8 | 36.6 | 9.3 | 5 | 7.1 | 0.4 | |
| 264.6 | 293.7 | 21.1 | 0.3 | 1.4 | 4.8 | 959.8 | 42.2 | |
| 3.8 | 475.4 | 1,402.3 | 33.0 | 4.5 | 7 | 14.4 | 1.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Indo Us Bio-Tech
Indo Us Bio-Tech Limited engages in the production, processing, packing, and marketing of seeds in India. The company offers vegetable seeds, such as tomato, okra, bottle gourd, brinjal, carrot, cluster bean, bitter gourd, ridge gourd, cucumber,... cabbage, radish, sponge gourd, pepper, chilly, sweet pepper, beet root, cow pea, corriander, onion, watermelon, musk melon, and flower seeds; cotton seeds; and oil seeds, including castor, groundnut, sesamum, mustard, and soyabean seeds. It also provides cumin and isabgul spices seeds; pulses seeds comprising val, gram, black gram, and green gram seeds; and cereals seeds consisting of wheat, maize, bajra, and pegeon pea seeds. It also exports its products. The company was incorporated in 2004 and is based in Ahmedabad, India. Read more
-
Incorporated
2004
-
Chairman
Jagdish Ajudia
-
Managing Director
Jagdish Ajudia
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Indo US Bio-Tech Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Indo Us Bio-Tech
What is the current share price of Indo US Bio-Tech Ltd Today?
The share price of Indo US Bio-Tech Ltd is ₹72.50 (NSE) and ₹72.00 (BSE) as of 14-Oct-2026 10:41 IST. Indo US Bio-Tech Ltd has given a return of -45.39% in the last 1 years.
What is the current PB & PE ratio of Indo US Bio-Tech Ltd?
The P/E ratio of Indo US Bio-Tech Ltd is 12.60 times as on 13-Oct-2026, a 13 discount to its peers’ median range of 14.42 times.
The P/B ratio of Indo US Bio-Tech Ltd is 1.51 times as on 13-Oct-2026, a 7 discount to its peers’ median range of 1.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
14.96 |
2.12 |
2025 |
18.15 |
3.76 |
2024 |
53.94 |
7.09 |
2023 |
14.71 |
3.91 |
2022 |
12.22 |
1.61 |
What is the 52 Week High and Low of Indo US Bio-Tech Ltd?
The 52-week high and low of Indo US Bio-Tech Ltd are Rs 159.00 and Rs 70.00 as of 14-Oct-2026.
What is the market cap of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd has a market capitalisation of ₹ 144 Cr as on 13-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Indo US Bio-Tech Ltd?
Before investing in Indo US Bio-Tech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.